<unk>  was shown not to interact with ethinyl estradiol, norgestimate or the migraine drug sumatriptan. It is expected to generally have a low potential for interactions because it is not metabolized by cytochrome P450 enzymes.
Erenumab
Anifrolumab
Alirocumab
Evolocumab
Emapalumab
Burosumab
Tralokinumab
Olaratumab